Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 504-505 [2019-28451]
Download as PDF
<![CDATA[
lotter on DSKBCFDHB2PROD with NOTICES
504
Federal Register / Vol. 85, No. 3 / Monday, January 6, 2020 / Notices
a.m. and 4:00 p.m., Monday through
Friday, except official State holidays
and official Federal holidays, at the
following offices: Nevada Department of
Environmental Protection, Admin
Office, 901 South Stewart Street, Suite
4001, Carson City, NV 89701; United
States Environmental Protection
Agency, Region 9, Drinking Water
Section, 75 Hawthorne Street (WTR4–1),
San Francisco, CA 94105.
Documents relating to this
determination are also available online
at https://ndep.nv.gov/posts/category/
public-notices for inspection.
FOR FURTHER INFORMATION CONTACT:
Jacob Jenzen, EPA Region 9, Drinking
Water Section, at the Region 9 address
provided above; via telephone at (415)
972–3570; or via email address at
Jenzen.Jacob@epa.gov.
SUPPLEMENTARY INFORMATION:
Background. The EPA approved the
State of Nevada’s original application
for PWSS program primary enforcement
authority on February 27, 1978 (43 FR
8030). Primacy states such as Nevada
must adopt and submit for approval to
EPA all new and revised national
primary drinking water regulations.
Since that initial approval, EPA has
worked with Nevada to review and
approve various revisions to Nevada’s
primacy program. For the revisions
covered by this action, the EPA
promulgated revisions to the Federal
Lead and Copper Rule with the Minor
Revisions on January 12, 2000 (65 FR
1950) and the Short-Term Revisions on
October 10, 2007 (72 FR 5778). Nevada
originally incorporated by reference the
requirements of the federal Lead and
Copper Rule, 40 CFR part 141 Subpart
I, directly into the Nevada
Administrative Code (NAC), and EPA
approved those revisions on July 21,
1996 (61 FR 29748). Nevada updated the
NAC with a rulemaking made effective
July 22, 2010 that expanded the
incorporation by reference of the
Federal Lead and Copper Rule to
include the Minor and Short-Term
Revisions, with language sufficient to
meet the federal requirements. These are
the primacy revisions that the EPA
Region 9 tentatively approves as part of
the Nevada’s PWSS Program.
Public Process. Any interested party
may request a public hearing on this
determination. A request for a public
hearing must be submitted by February
5, 2020, to the Regional Administrator
of EPA Region 9, to the address shown
above. The Regional Administrator may
deny frivolous or insubstantial requests
for a hearing. If a substantial request for
a public hearing is made by February 5,
2020, EPA Region 9 will hold a public
VerDate Sep<11>2014
17:53 Jan 03, 2020
Jkt 250001
hearing. Any request for a public
hearing shall include the following
information: 1. The name, address, and
telephone number of the individual,
organization, or other entity requesting
a hearing; 2. A brief statement of the
requesting person’s or organization’s
interest in the Regional Administrator’s
determination and a brief statement of
the information that the requesting
person intends to submit at such
hearing; and 3. The signature of the
individual making the request, or, if the
request is made on behalf of an
organization or other entity, the
signature of a responsible official of the
organization or other entity.
If EPA Region 9 does not receive a
timely and substantive request for a
hearing and the Regional Administrator
does not elect to hold a hearing on his
own motion, the determination at issue
in this notice, the EPA’s approval shall
become final and effective on February
5, 2020, and no further public notice
will be issued.
Authority: Section 1413 of the Safe
Drinking Water Act, 42 U.S.C. 300g–2 (1996),
and 40 CFR part 142 of the National Primary
Drinking Water Regulations.
Dated: December 17, 2019.
Deborah Jordan,
Acting Regional Administrator, EPA,
Region 9.
Misback, Secretary of the Board, 20th
and Constitution Avenue NW,
Washington DC 20551–0001, not later
than January 20, 2020.
A. Federal Reserve Bank of Kansas
City (Dennis Denney, Assistant Vice
President) 1 Memorial Drive, Kansas
City, Missouri 64198–0001:
1. Amanda Leigh Palmer, Erie,
Colorado; to acquire voting shares of
Wheeler County Bancshares, Inc., and
thereby indirectly acquire voting shares
of Ericson State Bank, both of Ericson,
Nebraska.
Board of Governors of the Federal Reserve
System, December 31, 2019.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2019–28481 Filed 1–3–20; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or the
Advisory Board), National Institute for
Occupational Safety and Health
(NIOSH)
BILLING CODE 6560–50–P
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
FEDERAL RESERVE SYSTEM
SUMMARY:
[FR Doc. 2019–28441 Filed 1–3–20; 8:45 am]
Change in Bank Control Notices;
Acquisitions of Shares of a Bank or
Bank Holding Company
The notificants listed below have
applied under the Change in Bank
Control Act (Act) (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire shares of a bank
or bank holding company. The factors
that are considered in acting on the
notices are set forth in paragraph 7 of
the Act (12 U.S.C. 1817(j)(7)).
The applications listed below, as well
as other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank indicated. The
applications will also be available for
inspection at the offices of the Board of
Governors. Interested persons may
express their views in writing on the
standards enumerated in paragraph 7 of
the Act.
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
PO 00000
Frm 00012
Fmt 4703
Sfmt 4703
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
of the Advisory Board on Radiation and
Worker Health (ABRWH). This meeting
is open to the public, but without a
public comment period. The public is
welcome to submit written comments in
advance of the meeting, to the contact
person below. Written comments
received in advance of the meeting will
be included in the official record of the
meeting. The public is also welcome to
listen to the meeting by joining the
audio conference (information below).
The audio conference line has 150 ports
for callers.
DATE: The meeting will be held on
February 19, 2020, 11:00 a.m. to 1:00
p.m., EST.
ADDRESS: Audio Conference Call via
FTS Conferencing. The USA toll-free
dial-in number is 1–866–659–0537; and
the pass code is 9933701.
FOR FURTHER INFORMATION CONTACT:
Theodore Katz, MPA, Designated
Federal Officer, NIOSH, CDC, 1600
Clifton Road, Mailstop E–20, Atlanta,
Georgia 30329–4017; Telephone: (513)
E:\FR\FM\06JAN1.SGM
06JAN1
lotter on DSKBCFDHB2PROD with NOTICES
Federal Register / Vol. 85, No. 3 / Monday, January 6, 2020 / Notices
533–6800; Toll Free: 1 (800) CDC–INFO;
Email: ocas@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines
which have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule, advice on
methods of dose reconstruction which
have also been promulgated by HHS as
a final rule, advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program, and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC). In
December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS,
which subsequently delegated this
authority to the CDC. NIOSH
implements this responsibility for CDC.
The Advisory Board’s charter was
issued on August 3, 2001, renewed at
appropriate intervals, rechartered on
February 12, 2018, and will terminate
on February 12, 2020.
Purpose: This Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advising the Secretary
on whether there is a class of employees
at any Department of Energy facility
who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters To Be Considered: The agenda
will include discussions on: Work
Group and Subcommittee Reports;
Update on the Status of SEC Petitions;
Plans for the April 2020 Advisory Board
Meeting; and Advisory Board
Correspondence. Agenda items are
subject to change as priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
VerDate Sep<11>2014
17:53 Jan 03, 2020
Jkt 250001
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2019–28451 Filed 1–3–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Center for State, Tribal, Local, and
Territorial Support (CSTLTS), CDC/
ATSDR Tribal Advisory Committee
(TAC) Meeting
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
The Centers for Disease
Control and Prevention (CDC)/Agency
for Toxic Substances and Disease
Registry (ATSDR), announces the
Winter 2020 CDC/ATSDR Tribal
Advisory Committee (TAC) meeting.
The meeting is being hosted by CDC/
ATSDR, in-person only, and is open to
the public, except for certain hours set
aside for tribal caucus. Attendees must
pre-register for the event by Friday,
February 21, 2020, at the following link:
https://www.cdc.gov/tribal/
meetings.html.
SUMMARY:
The meeting will be held March
12, 2020, 9:30 a.m. to 5:30 p.m., EDT;
and March 13, 2020, 9:30 a.m. to 5:30
p.m., EDT.
ADDRESSES: CDC, Chamblee Campus,
Building 106, Rooms 1A/1B, 4770
Buford Highway, Atlanta, GA 30341–
3717.
DATES:
FOR FURTHER INFORMATION CONTACT:
CAPT Carmen Clelland, PharmD, MPA,
MPH, Director, Office of Tribal Affairs
and Strategic Alliances, Center for State,
Tribal, Local, and Territorial Support,
CDC, 4770 Buford Highway, Mailstop
V18–4, Atlanta, GA 30341–3717;
Telephone: (404) 498–2205; Email:
cclelland@cdc.gov.
SUPPLEMENTARY INFORMATION: This
meeting is being held in accordance
with Presidential Executive Order No.
13175, November 6, 2000, and the
Presidential Memorandum of November
5, 2009, and September 23, 2004,
PO 00000
Frm 00013
Fmt 4703
Sfmt 4703
505
Consultation and Coordination with
Indian Tribal Governments.
Purpose: The purpose of the TAC
meeting is to advance CDC/ATSDR
support for and collaboration with
American Indian and Alaska Native (AI/
AN) tribal nations and to improve the
health of AI/AN people by pursuing
goals that include assisting in
eliminating the health disparities faced
by tribal nations; ensuring that access to
critical health and human services and
public health services is maximized to
advance or enhance the social, physical,
and economic status of AI/AN people;
and promoting health equity for all AI/
AN people and communities. To
advance these goals, CDC/ATSDR
conducts government-to-government
meetings with elected tribal officials or
their authorized representatives. These
meetings offer open and free exchange
of information and opinion among
parties that leads to mutual
understanding.
Information about the TAC, CDC/
ATSDR’s Tribal Consultation Policy,
and previous meetings is available at
https://www.cdc.gov/tribal/
consultation-support/tribalconsultation/sessions.html.
Matters To Be Considered: The agenda
will include discussions on tribal
priorities for CDC and ATSDR, public
health capacity in Indian Country, and
programmatic highlights. AI/AN tribal
nations also will have an opportunity to
present testimony about tribal health
issues. All tribal leaders are encouraged
to submit written testimony by 5:00
p.m. (EST) Friday, February 21, 2020, to
Captain Carmen Clelland, Director,
Office of Tribal Affairs and Strategic
Alliances, via mail at 4770 Buford
Highway, Mailstop V18–4, Atlanta, GA
30341–3717, or by email to
TribalSupport@cdc.gov. Guidance for
developing tribal testimony for CDC/
ATSDR is available at www.cdc.gov/
tribal/consultation-support/tac/
index.html. Based on the number of
tribal leaders giving testimony and the
time available, it may be necessary to
limit the time for each presenter.
Agenda items are subject to change as
priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
E:\FR\FM\06JAN1.SGM
06JAN1
]]>Agencies
[Federal Register Volume 85, Number 3 (Monday, January 6, 2020)]
[Notices]
[Pages 504-505]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-28451]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH or the
Advisory Board), National Institute for Occupational Safety and Health
(NIOSH)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting of the Advisory Board on Radiation and
Worker Health (ABRWH). This meeting is open to the public, but without
a public comment period. The public is welcome to submit written
comments in advance of the meeting, to the contact person below.
Written comments received in advance of the meeting will be included in
the official record of the meeting. The public is also welcome to
listen to the meeting by joining the audio conference (information
below). The audio conference line has 150 ports for callers.
DATE: The meeting will be held on February 19, 2020, 11:00 a.m. to 1:00
p.m., EST.
ADDRESS: Audio Conference Call via FTS Conferencing. The USA toll-free
dial-in number is 1-866-659-0537; and the pass code is 9933701.
FOR FURTHER INFORMATION CONTACT: Theodore Katz, MPA, Designated Federal
Officer, NIOSH, CDC, 1600 Clifton Road, Mailstop E-20, Atlanta, Georgia
30329-4017; Telephone: (513)
[[Page 505]]
533-6800; Toll Free: 1 (800) CDC-INFO; Email: [email protected].
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing advice
on the development of probability of causation guidelines which have
been promulgated by the Department of Health and Human Services (HHS)
as a final rule, advice on methods of dose reconstruction which have
also been promulgated by HHS as a final rule, advice on the scientific
validity and quality of dose estimation and reconstruction efforts
being performed for purposes of the compensation program, and advice on
petitions to add classes of workers to the Special Exposure Cohort
(SEC). In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the CDC. NIOSH implements this
responsibility for CDC. The Advisory Board's charter was issued on
August 3, 2001, renewed at appropriate intervals, rechartered on
February 12, 2018, and will terminate on February 12, 2020.
Purpose: This Advisory Board is charged with (a) providing advice
to the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advising the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered the health of members of this class.
Matters To Be Considered: The agenda will include discussions on:
Work Group and Subcommittee Reports; Update on the Status of SEC
Petitions; Plans for the April 2020 Advisory Board Meeting; and
Advisory Board Correspondence. Agenda items are subject to change as
priorities dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-28451 Filed 1-3-20; 8:45 am]
BILLING CODE 4163-18-P
